These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 8900045

  • 1. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
    Wright WE, Dac-Korytko I, Farmer K.
    Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
    [Abstract] [Full Text] [Related]

  • 2. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS, Liu S, Wang SW, Schmidt J.
    J Mol Biol; 2002 Mar 29; 317(3):431-45. PubMed ID: 11922675
    [Abstract] [Full Text] [Related]

  • 3. Multimeric structures influence the binding activity of bHLH muscle regulatory factors.
    Wright WE, Catala F, Farmer K.
    Symp Soc Exp Biol; 1992 Mar 29; 46():79-87. PubMed ID: 1341052
    [Abstract] [Full Text] [Related]

  • 4. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains.
    Beltran AC, Dawson PE, Gottesfeld JM.
    Chembiochem; 2005 Jan 29; 6(1):104-13. PubMed ID: 15593070
    [Abstract] [Full Text] [Related]

  • 5. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
    Maleki SJ, Royer CA, Hurlburt BK.
    Biochemistry; 1997 Jun 03; 36(22):6762-7. PubMed ID: 9184158
    [Abstract] [Full Text] [Related]

  • 6. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity.
    Lu J, Sloan SR.
    Biochem Biophys Res Commun; 2002 Feb 08; 290(5):1521-8. PubMed ID: 11820794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Negative regulation of selected bHLH proteins by eHAND.
    Bounpheng MA, Morrish TA, Dodds SG, Christy BA.
    Exp Cell Res; 2000 Jun 15; 257(2):320-31. PubMed ID: 10837146
    [Abstract] [Full Text] [Related]

  • 12. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR, Richardson JA, Klein WH, Olson EN.
    Dev Biol; 2000 Mar 15; 219(2):287-98. PubMed ID: 10694423
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
    Maleki SJ, Royer CA, Hurlburt BK.
    Biochemistry; 2002 Sep 03; 41(35):10888-94. PubMed ID: 12196028
    [Abstract] [Full Text] [Related]

  • 14. Covalently linking BHLH subunits of MASH-1 increases specificity of DNA binding.
    Künne AG, Allemann RK.
    Biochemistry; 1997 Feb 04; 36(5):1085-91. PubMed ID: 9033398
    [Abstract] [Full Text] [Related]

  • 15. Thermodynamics of the DNA binding reaction of transcription factor MASH-1.
    K-unne AG, Sieber M, Meierhans D, Allemann RK.
    Biochemistry; 1998 Mar 24; 37(12):4217-23. PubMed ID: 9521744
    [Abstract] [Full Text] [Related]

  • 16. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP, Duncan JL, Lee C, Kuchel PW, Matthews JM.
    Proteins; 2008 Mar 24; 70(4):1461-74. PubMed ID: 17910069
    [Abstract] [Full Text] [Related]

  • 17. The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization.
    Steingrímsson E, Nii A, Fisher DE, Ferré-D'Amaré AR, McCormick RJ, Russell LB, Burley SK, Ward JM, Jenkins NA, Copeland NG.
    EMBO J; 1996 Nov 15; 15(22):6280-9. PubMed ID: 8947051
    [Abstract] [Full Text] [Related]

  • 18. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S, Tremblay L, Lavigne P.
    J Mol Biol; 2004 Sep 17; 342(3):813-32. PubMed ID: 15342239
    [Abstract] [Full Text] [Related]

  • 19. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
    Menz B, Sester M, Koebernick K, Schmid R, Burgert HG.
    Mol Immunol; 2008 Nov 17; 46(1):16-26. PubMed ID: 18692902
    [Abstract] [Full Text] [Related]

  • 20. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM, Wurtz JM, Wasylyk B.
    EMBO J; 1996 Nov 01; 15(21):5849-65. PubMed ID: 8918463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.